Arabinosylcytosine Induces Fetal Hemoglobin in Baboons by Perturbing Erythroid Cell Differentiation Kinetics-Reference-Cited by-同舟云学术

Arabinosylcytosine Induces Fetal Hemoglobin in Baboons by Perturbing Erythroid Cell Differentiation Kinetics

Published:1984-05-11 Issue:4649 Volume:224 Page:617-619
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Papayannopoulou Thalia¹,Torrealba de Ron Ana¹,Veith Robert¹,Knitter G.²,Stamatoyannopoulos G.³

Affiliation:

1. Division of Hematology, Department of Medicine, University of Washington, Seattle 98195

2. Regional Primate Center, University of Washington, Seattle

3. Division of Medical Genetics, Department of Medicine, University of Washington, Seattle 98195

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference17 articles.

1. Charache, S., Proceedings of the National Academy of Sciences of the United States of America 80: 4842 (1983).

2. DESFORGES, J.F., CYTARABINE - LOW-DOSE, HIGH-DOSE, NO DOSE, NEW ENGLAND JOURNAL OF MEDICINE 309: 1637 (1983).

3. DeSimone, J., Proceedings of the National Academy of Sciences of the United States of America 79: 4428 (1982).

4. FAUSER, A.A., PROLIFERATIVE STATE OF HUMAN PLURIPOTENT HEMATOPOIETIC PROGENITORS (CFU-GEMM) IN NORMAL INDIVIDUALS AND UNDER REGENERATIVE CONDITIONS AFTER BONE-MARROW TRANSPLANTATION, BLOOD 54: 1197 (1979).

5. ISCOVE, N.N., ERYTHROID PROGENITORS IN MOUSE BONE-MARROW DETECTED BY MACROSCOPIC COLONY FORMATION IN CULTURE, EXPERIMENTAL HEMATOLOGY 3: 32 (1975).

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic and Biological Perspectives on Erythropoiesis;Experimental Hematology;2024-10

2. Sickle cell disease: progress towards combination drug therapy;British Journal of Haematology;2021-01-20

3. Sickle Hepatopathy;Journal of Clinical and Experimental Hepatology;2021-01

4. Control of fetal globin expression in man: new opportunities to challenge past discoveries;Experimental Hematology;2020-12

5. Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease;Journal of Clinical Medicine;2020-07-17